Published 11 months ago

Pfizer warns FDA of shrinking penicillin supply

Pfizer warned that it will run out of several doses of penicillin that treat syphilis, strep throat, and other infections later this year due to supply chain shortages in the US.
The company anticipates running out of the children's dose of the syphilis drug Bicillin L-A by the end of June and that a different penicillin, Bicillin C-R, is expected to run out in the third quarter.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

The Hill

Pfizer warns FDA of shrinking penicillin supply

Pfizer cited a "complex combination of factors" for the shortage, including an increase in demand and a rise in syphilis rates.

11 months ago·Washington, United States

Read Full Article

Bloomberg

Pfizer Sees Antibiotic Supply Running Out as Shortage Worsens

Pfizer Inc. will run out of several doses of penicillin, which treats syphilis, strep throat, and other infections, later this year as shortages ripple across the US’s antibiotic supply.

11 months ago·United States

Read Full Article

OC Register

Pfizer sees antibiotic supply running out as shortage worsens

It will run out of several types of penicillin, which treat syphilis, strep throat and other infections, later this year.

11 months ago·Orange County, United States

Read Full Article

WTVB

Pfizer expects to run out of antibiotic supply soon

(Reuters) - Pfizer has warned that a drug used to treat syphilis and other bacterial infections in children could run out by the end of June as a spike in infections has put pressure on an already short supply of the antibiotic. Supply of the drug, Bicillin L-A, is expected to be exhausted by the end of this quarter, the company said in a letter to the U.S. health regulator dated Monday. Pfizer's penicillin products have been in shortage sin…

11 months ago

Read Full Article

WTEN

Pfizer warns FDA of shrinking penicillin supply

(The Hill) -- The ongoing drug shortages impacting the U.S. are now threatening to exhaust two commonly used forms of penicillin, Pfizer said in a warning to the Food and Drug Administration (FDA) on Monday. Pfizer alerted the FDA that there is "a limited supply and impending stock out" of Bicillin L-A and Bicillin C-R, two of its injectable penicillin products. Get the latest, news, weather, sports and community events delivered right to y…

11 months ago·Albany, United States

Read Full Article